Scientists at McMaster University who have developed an inhaled form of COVID vaccine have confirmed it can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
Feb 10, 2022
0
2560
Cases of the Wuhan coronavirus have increased dramatically over the past week, prompting concerns about how contagious the virus is and how it spreads.
Jan 28, 2020
0
5
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those ...
May 13, 2020
0
766
Some people question why the current coronavirus has brought the world to standstill while a previous deadly coronavirus, SARS, did not.
May 5, 2020
0
1
Researchers may finally have an answer in the long-running controversy over whether the common surgical mask is as effective as more expensive respirator-type masks in protecting health care workers from flu and other respiratory ...
Sep 3, 2019
0
44
Expectant mothers in London are among the first in the world to participate in a clinical trial of a possible vaccine against a virus which causes life threatening breathing problems in babies.
Oct 4, 2017
0
321
Thanks to the sniffling noses, coughs, and colds that accompany the colder months of the year, we are all too familiar with the seasonal patterns of some respiratory viruses. A new review published in Frontiers in Public ...
Sep 15, 2020
0
264
Winter is on its way. And in this year of coronavirus, with it comes the potential for a second wave of COVID-19. Add in flu season and our tendency to head inside and close our windows to the cold, wet weather, and it appears ...
Oct 14, 2020
0
224
Messenger RNA vaccine technology, once an arcane area of research, became household terminology because of the COVID-19 pandemic, and now scientists are working on an mRNA flu vaccine strategy that, at least in this study, ...
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
